• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[原发性血小板增多症。61例临床、生物学及发育学研究]

[Essential thrombocythemia. Clinical, biological study and developmental study of 61 cases].

作者信息

Simon M, Jouet J P, Huart J J, Demory J L, Bauters F

出版信息

Sem Hop. 1984 Apr 19;60(17):1173-9.

PMID:6326310
Abstract

The 61 observations of primary thrombocythemia described in this report represent approximately 15% of the cases of polycythemia vera recorded by the authors over the same 18-year period. The group includes 35 females and 26 males, with a mean age of 62. The disease is usually discovered on routine blood tests (half of cases), and more rarely because of hemorrhagic or thrombotic manifestations. Splenomegaly is found in one-third of cases. Platelet count is permanently above 800 X 10(9)/l (mean : 1 500 X 10(9)/l); mild hyperleukocytosis (mean : 16 X 10(9)/l) with predominant neutrophil polynuclears is usual but myelemia is not constant (28% of cases) and always very moderate; red cell parameters are normal in three-fourths of cases, while the remaining patients have anemia, either due to iron depletion or not. Reticulinic myelofibrosis, usually minimal, is found in 40% of cases. Medullary karyotype is always normal, without chromosome Ph1. Platelet functional abnormalities are not constant and do not correlate with the magnitude of thrombocythemia. 51 patients (84%) received myelosuppressive therapy, mainly by busulfan or radioactive phosphorus. Most deaths were due to intercurrent causes and only one patient developed acute leukemia. 71% of patients are alive at five years and subsequent decrease in the actuarial survival curve is very gradual.

摘要

本报告中描述的61例原发性血小板增多症病例约占作者在同一18年期间记录的真性红细胞增多症病例的15%。该组包括35名女性和26名男性,平均年龄为62岁。该病通常在常规血液检查时被发现(半数病例),因出血或血栓形成表现而被发现的情况较少。三分之一的病例有脾肿大。血小板计数持续高于800×10⁹/L(平均:1500×10⁹/L);通常有轻度白细胞增多(平均:16×10⁹/L),以中性多形核白细胞为主,但骨髓白血病并不常见(28%的病例)且程度总是很轻;四分之三的病例红细胞参数正常,其余患者有贫血,原因可能是缺铁或其他因素。40%的病例有网状骨髓纤维化,通常很轻微。骨髓核型始终正常,无Ph1染色体。血小板功能异常并不常见,且与血小板增多的程度无关。51例患者(84%)接受了骨髓抑制治疗,主要是使用白消安或放射性磷。大多数死亡是由并发原因导致的,只有1例患者发展为急性白血病。71%的患者在5年后仍然存活,精算生存曲线随后的下降非常缓慢。

相似文献

1
[Essential thrombocythemia. Clinical, biological study and developmental study of 61 cases].[原发性血小板增多症。61例临床、生物学及发育学研究]
Sem Hop. 1984 Apr 19;60(17):1173-9.
2
Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.真性红细胞增多症、原发性血小板增多症和骨髓纤维化伴髓样化生患者接受羟基脲治疗的白血病发生风险。
Am J Hematol. 1996 May;52(1):42-6. doi: 10.1002/(SICI)1096-8652(199605)52:1<42::AID-AJH7>3.0.CO;2-6.
3
Essential thrombocythemia following polycythemia vera: an unusual sequence.真性红细胞增多症后出现的原发性血小板增多症:一种不寻常的病程。
J Med. 1996;27(5-6):363-8.
4
Aspirin-responsive painful red, blue, black toe, or finger syndrome in polycythemia vera associated with thrombocythemia.真性红细胞增多症伴血小板增多症中阿司匹林反应性疼痛性红、蓝、黑趾或指综合征
Ann Hematol. 2003 Mar;82(3):153-9. doi: 10.1007/s00277-002-0593-x. Epub 2003 Feb 12.
5
[Radioactive phosphorus (32P); an old but not bad treatment for polycythemia vera].[放射性磷(32P);真性红细胞增多症的一种虽旧但不错的治疗方法]
Ned Tijdschr Geneeskd. 1996 Sep 21;140(38):1900-2.
6
Essential thrombocythemia: a relative benign long-term course.原发性血小板增多症:相对良性的长期病程。
Isr J Med Sci. 1993 Apr;29(4):190-4.
7
Efficacy trial of pipobroman in essential thrombocythemia: a study of 24 patients.哌泊溴烷治疗原发性血小板增多症的疗效试验:24例患者的研究
Cancer Treat Rep. 1984 Nov;68(11):1339-42.
8
Essential thrombocythemia: response during first year of therapy with melphalan and radioactive phosphorus: a polycythemia Vera Study Group report.
Cancer Treat Rep. 1982 Jul;66(7):1495-500.
9
NTP Toxicology and Carcinogenesis Studies of Scopolamine Hydrobromide Trihydrate (CAS No. 6533-68-2) in F344 Rats and B6C3F1 Mice (Gavage Studies).三水合氢溴酸东莨菪碱(CAS编号:6533-68-2)在F344大鼠和B6C3F1小鼠中的NTP毒理学与致癌性研究(灌胃研究)
Natl Toxicol Program Tech Rep Ser. 1997 Mar;445:1-277.
10
Characteristic changes in platelet-large cell ratio, lactate dehydrogenase and C-reactive protein in thrombocytosis-related diseases.血小板大细胞比率、乳酸脱氢酶及C反应蛋白在血小板增多相关疾病中的特征性变化。
Acta Haematol. 2007;118(2):84-7. doi: 10.1159/000105167. Epub 2007 Jul 10.

引用本文的文献

1
[Clinical characterization of essential thrombocythemia in comparison to other myeloproliferative diseases and reactive thrombocytoses].[与其他骨髓增殖性疾病及反应性血小板增多症相比,原发性血小板增多症的临床特征]
Klin Wochenschr. 1988 Aug 1;66(15):699-702. doi: 10.1007/BF01726930.
2
[Clinical characterization of essential thrombocythemia in comparison with other myeloproliferative diseases and reactive thrombocytoses].[原发性血小板增多症与其他骨髓增殖性疾病及反应性血小板增多症的临床特征比较]
Klin Wochenschr. 1988 Mar 1;66(5):190-8. doi: 10.1007/BF01728196.